Hong Kong: Fosun Pharma to increase stake in Sisram Medical

Liu Yi, chairman, Sisram Medical

Chinese listed pharmaceutical company Fosun Pharma intends to up its stake in medical aesthetics device manufacturer Sisram Medical. Already a majority shareholder in the Hong Kong-listed company, it plans to increase its stake from 52.8% to 74.8% for around US$52.6m. It plans to buy 97 million shares from what it calls “a substantial shareholder of…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »